Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Yang, 2010, Hepatocellular carcinoma: a global view., Nat Rev Gastroenterol Hepatol, 7, 448, 10.1038/nrgastro.2010.100
Bruix, 2014, Hepatocellular carcinoma: clinical frontiers and perspectives., Gut, 63, 844, 10.1136/gutjnl-2013-306627
Chan, 2008, Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening., Ann Surg, 247, 666, 10.1097/SLA.0b013e31816a747a
Imamura, 2003, Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy., J Hepatol, 38, 200, 10.1016/S0168-8278(02)00360-4
Minagawa, 2003, Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma., Ann Surg, 238, 703, 10.1097/01.sla.0000094549.11754.e6
Zhang, 2015, Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern., Eur J Gastroenterol Hepatol, 27, 933, 10.1097/MEG.0000000000000383
Hasegawa, 2013, Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey., J Hepatol, 58, 724, 10.1016/j.jhep.2012.11.009
Poon, 2000, Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma., Cancer, 89, 500, 10.1002/(ISSN)1097-0142
Portolani, 2006, Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications., Ann Surg, 243, 229, 10.1097/01.sla.0000197706.21803.a1
Zheng, 2017, Prediction of hepatocellular carcinoma recurrence beyond Milan criteria after resection: validation of a clinical risk score in an international cohort., Ann Surg, 266, 693, 10.1097/SLA.0000000000002360
Poon, 2009, Differentiating early and late recurrences after resection of HCC in cirrhotic patients: implications on surveillance, prevention, and treatment strategies., Ann Surg Oncol, 16, 792, 10.1245/s10434-009-0330-y
Du, 2014, Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution’s experience with 398 consecutive patients., Hepatobiliary Pancreat Dis Int, 13, 153, 10.1016/S1499-3872(14)60025-4
Huang, 2013, Early recurrence after curative resection in oligonodular hepatocellular carcinoma., Hepatogastroenterology, 60, 28
Cheng, 2015, Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection., HPB (Oxford), 17, 422, 10.1111/hpb.12367
Rou, 2014, Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization., World J Gastroenterol, 20, 6995, 10.3748/wjg.v20.i22.6995
Lee, 2013, Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors., Eur Radiol, 23, 190, 10.1007/s00330-012-2561-8
Montasser, 2014, Risk factors for early intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma in Egyptian patients., J Dig Dis, 15, 676, 10.1111/cdd.2014.15.issue-12
Zhou, 2010, Risk factors for early recurrence of small hepatocellular carcinoma after curative resection., Hepatobiliary Pancreat Dis Int, 9, 33
Shimoda, 2016, Risk factors for early recurrence of single lesion hepatocellular carcinoma after curative resection., World J Surg, 40, 2466, 10.1007/s00268-016-3529-7
Yamamoto, 2015, Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy., World J Gastroenterol, 21, 1207, 10.3748/wjg.v21.i4.1207
World Medical Association, 2013, World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects., JAMA, 310, 2191, 10.1001/jama.2013.281053
Strasberg, 2013, Use and dissemination of the Brisbane 2000 nomenclature of liver anatomy and resections., Ann Surg, 257, 377, 10.1097/SLA.0b013e31825a01f6
Pecchi, 2015, Post-transplantation hepatocellular carcinoma recurrence: patterns and relation between vascularity and differentiation degree., World J Hepatol, 7, 276, 10.4254/wjh.v7.i2.276
Schmidt, 2010, Molecular signature for HCC: role in predicting outcomes after liver transplant and selection for potential adjuvant treatment., Curr Opin Organ Transplant, 15, 277, 10.1097/MOT.0b013e328339837b
White, 2017, Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012., Gastroenterology, 152, 812, 10.1053/j.gastro.2016.11.020
Lee, 1999, Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection., Cancer, 86, 1143, 10.1002/(ISSN)1097-0142
El-Serag, 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis., Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061
Villa, 1995, Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma., Cancer Res, 55, 498
De Maria, 2002, Sex hormones and liver cancer., Mol Cell Endocrinol, 193, 59, 10.1016/S0303-7207(02)00096-5
Nagasue, 1989, Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women., Cancer, 63, 112, 10.1002/(ISSN)1097-0142
Hassan, 2017, Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma., Clin Gastroenterol Hepatol, 15, 1791, 10.1016/j.cgh.2017.05.036
Cucchetti, 2009, Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population., Ann Surg Oncol, 16, 413, 10.1245/s10434-008-0232-4
El-Serag, 2012, Epidemiology of viral hepatitis and hepatocellular carcinoma., Gastroenterology, 142, 1264, 10.1053/j.gastro.2011.12.061
Morgan, 2004, Alcohol and hepatocellular carcinoma., Gastroenterology, 127, S87, 10.1053/j.gastro.2004.09.020
Dyson, 2014, Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team., J Hepatol, 60, 110, 10.1016/j.jhep.2013.08.011